Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
34%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
FHLC
334
HOLDINGS
5%
ALSO IN PPH
PPH
27
HOLDINGS
70%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.0% | 19.1% | 13.0% |
|
JOHNSON & JOHNSON | 7.5% | 4.7% | 4.7% |
|
ABBVIE INC | 6.1% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 4.0% | 9.6% | 4.0% |
|
PFIZER INC | 2.1% | 4.7% | 2.1% |
FHLC Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 4.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
ABBOTT LABORATORIES | 3.3% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
JOHNSON & JOHNSON | 2.8% |
|
AMGEN INC | 2.7% |
|
GILEAD SCIENCES INC | 2.3% |
|
DANAHER CORP | 2.2% |
|
BOSTON SCIENTIFIC CORP | 2.1% |
|
ABBVIE INC | 2.1% |
FHLC Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.6% |
|
ELI LILLY & CO | -6.1% |
|
MERCK & CO. INC. | -5.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.6% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -5.0% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.2% |
|
MCKESSON CORP | -3.2% |
|
CENCORA INC | -3.0% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.8% |